Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (‘Listing Regulations’), Fredun Pharmaceuticals has informed that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors have, vide Resolution dated 28th November, 2025 have appointed Pooja Narendra Sanghavi (DIN: 11387388) as an Additional Director in the category of Independent Director of the Company for a term of five years with effect from 28th November, 2025 subject to the approval of shareholders. The brief profile of Pooja Narendra Sanghavi (DIN: 11387388) is enclosed as ‘Annexure – I’. Pursuant to Regulation 30 of SEBI (Listing obligations & Disclosure Requirements) Regulations, 2015 Read with Schedule III (Part A) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, it has informed that the Board of Directors of the Company at their meeting held on November 28, 2025 has approved Appointment of Vaishnavi Sahu as the Company Secretary and Compliance Officer of the Company with effect from November 28, 2025. The brief profile of Vaishnavi Sahu is enclosed as ‘Annexure – II’.
